Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
7
×
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
clinical trials
europe blog main
europe top stories
gene therapy
merck
pfizer
arimoclomol
astrazeneca
cancer
cancer immunotherapy
gilead sciences
glaxosmithkline
What
cancer
7
×
bio
roundup
amid
bombast
caught
coronavirus
debate
develop
discussion
drug
efforts
medical
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
abbvie’s
advanced
ahead
annual
arrival
ash
award
barcelona
biofourmis
blood
broader
bucks
celebrate
chance
clinical
company
conference
Language
unset
7
×
Current search:
cancer
×
unset
×
" raleigh-durham top stories "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
